Nancy S. Lurker

Nancy Lurker - Board Member - National Board of Directors

Board Member

Nancy Lurker is a highly regarded CEO with more than 25 years of experience in the biopharmaceutical industry and more recently in molecular diagnostics. Known for her leadership, innovation, and ability to work with scientists and R&D departments to accelerate the development of new patient therapies, she currently serves as a Board Director of Mallinckrodt Pharmaceuticals.

Lurker was President and CEO and Board Director for PDI, a leading commercial services company to the biopharmaceutical industry. She led PDI through significant change in the industry, growing its market share, pivoting into molecular diagnostics and ultimately executing a sale of PDI’s core business.

Prior to joining PDI, Lurker served as Senior Vice President and Chief Marketing Officer for Novartis Pharmaceuticals Corporation (the U.S. subsidiary of Novartis AG), in which capacity she managed a product portfolio that included multiple therapeutic areas representing billions of dollars in annual sales. She also served as President and CEO of ImpactRx, Group Vice President-Global Primary Care Products for Pharmacia Corporation, and as a member of Pharmacia’s U.S. Executive Management Committee.

Lurker began her career at Bristol Myers Squibb, where she ascended from Senior Sales Representative to Senior Director of Worldwide Cardiovascular Franchise Management during her 14-year tenure.

Lurker received a Bachelor of Science degree in biology magna cum laude from Seattle Pacific University, and earned an MBA from the University of Evansville.